Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality

NCT ID: NCT02668250

Last Updated: 2021-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

2495 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-03

Study Completion Date

2021-03-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

With the increasing aging population demographics and life expectancies, the number of very elderly patients undergoing surgery is rising. Elderly patients constitute an increasingly large proportion of the high-risk surgical group.

Cardiac complications and postoperative pulmonary complications are equally prevalent and contribute similarly to morbidity, mortality, and length of hospital stay. Specific optimization strategy of general anesthesia has been tested in high-risk patients undergoing major surgery to improve outcomes.

Our hypothesis is that a combined optimization strategy of anesthesia concerning hemodynamic, ventilation, and depth of anesthesia may improve short- and long- term outcome in elderly undergoing high risk surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The population is expanding and aging. With the increasing aging population demographics and life expectancies, the number of very elderly patients (age ≥ 75) undergoing surgery is rising. Elderly patients constitute an increasingly large proportion of the high-risk surgical group. In 2010, patients aged 75 yrs and over represented only 2.1% of patients undergoing high risk surgery in France (PMSI database), but concentrated 27% of in-hospital deaths.

Cardiac complications and postoperative pulmonary complications are equally prevalent and contribute similarly to morbidity, mortality, and length of hospital stay. Specific optimization strategy of general anesthesia has been tested in high-risk patients undergoing major surgery to improve outcomes. Meta-analyses have demonstrated that goal directed hemodynamic therapy significantly reduced mortality and surgical complications in high-risk patients. A lung-protective ventilation strategy in high-risk patients undergoing major abdominal surgery was associated with improved clinical outcome. Retrospective studies indicated that a combination of excessive depth of anesthesia, hypotension and low anesthesia requirement resulted in increased mortality. These approaches of peroperative care remain discussed in the literature and have also to be incorporated in the common clinical practice. Moreover, few of these reviews performed a sensitive analysis in the elderly.

Whether a multi-parametric optimization strategy of anesthesia including several specific interventions will impact the short-term postoperative major morbidity and mortality in elderly is not known. The addition of depth of anesthesia monitoring to hemodynamic monitoring and goal directed hemodynamic therapy may improve tissue perfusion by reducing hemodynamic side effects of anesthetic agents, particularly in elderly where the therapeutic window of these agents is reduced. The effects of low protective ventilation may also by additive to the previous measures by reducing the perioperative build-up of oxygen debt. Our hypothesis is that a combined optimization strategy of anesthesia concerning hemodynamic, ventilation, and depth of anesthesia may improve short- and long- term outcome in elderly undergoing high risk surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary; Ischemic Arrhythmias, Cardiac Heart Failure Peripheral Vascular Diseases Dementia Stroke Pulmonary Disease, Chronic Obstructive Respiratory Insufficiency Alcoholism Cancer Diabetes Renal Insufficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group : OPTI-AGED

The OPTI-AGED group will receive a combined optimization strategy of anesthesia concerning hemodynamic, ventilation, and depth of anesthesia.

Group Type EXPERIMENTAL

OPTI-AGED

Intervention Type PROCEDURE

OPTI-AGED is composed of a multi-parametric optimization strategy.

Control Group :

The control group will not benefit from the OPTI-AGED intervention but patients will receive the usual care.

Group Type ACTIVE_COMPARATOR

Usual Care

Intervention Type PROCEDURE

Patients receive the usual care.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Usual Care

Patients receive the usual care.

Intervention Type PROCEDURE

OPTI-AGED

OPTI-AGED is composed of a multi-parametric optimization strategy.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All adult patients aged 75 years and over,
* presenting at least one of the following comorbidities: ischemic coronary disease; cardiac arrhythmia; congestive heart failure; peripheral vascular disease; dementia; stroke; chronic obstructive pulmonary disease; chronic respiratory failure; chronic alcohol abuse; active cancer; diabetes; chronic renal failure A comorbidity index will be measured by using the modified Charlson Comorbidity Index
* undergoing elective and emergency surgeries including : femoral head fracture, major intraperitoneal abdominal surgery lasting \> 90 min (excluding elective cholecystectomy, abdominal wall surgery), vascular surgery (excluding venous surgery and fistula creation)
* Patient's or patient's relative signed consent form
* Affiliation to French social assurance system

Exclusion Criteria

* Acute heart failure and acute coronary syndrome
* Acute respiratory failure, pneumonia
* Septic shock
* Delirium
* Acute stroke
* Evolutive neuromuscular disorder
* Thoracic surgery, combined abdominal and thoracic surgery
* Surgery performed under exclusive regional anesthesia
* Patients under tutorship or curatorship
* Refusal to participate
Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Health, France

OTHER_GOV

Sponsor Role collaborator

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MOLLIEX Serge, MD

Role: PRINCIPAL_INVESTIGATOR

CHU SAINT-ETIENNE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Amiens - Picardie

Amiens, , France

Site Status

CHU CAEN

Caen, , France

Site Status

Chu Clermont-Ferrand

Clermont-Ferrand, , France

Site Status

Médipôle Lyon - Villeurbanne

Décines-Charpieu, , France

Site Status

Chu Dijon

Dijon, , France

Site Status

Chu Grenoble

Grenoble, , France

Site Status

CHRU Lille - Salengro

Lille, , France

Site Status

CHU LILLE - Huriez

Lille, , France

Site Status

CHU LYON

Lyon, , France

Site Status

Lyon Sud - CHU

Lyon, , France

Site Status

Chu Marseille La Timone

Marseille, , France

Site Status

Chu Marseille Nord

Marseille, , France

Site Status

Chu Montpellier

Montpellier, , France

Site Status

Chu Nancy

Nancy, , France

Site Status

CHU de Nantes

Nantes, , France

Site Status

CHU NICE

Nice, , France

Site Status

Chu Nimes

Nîmes, , France

Site Status

Ch Paris Beaujon

Paris, , France

Site Status

Ch Paris Bichat

Paris, , France

Site Status

Ch Paris Pitie Salpetriere

Paris, , France

Site Status

Ch Paris Saint Antoine

Paris, , France

Site Status

Ch Saint Louis-Lariboisiere

Paris, , France

Site Status

Chu Poitiers

Poitiers, , France

Site Status

Chu Rennes

Rennes, , France

Site Status

Chu Rouen

Rouen, , France

Site Status

Chu Saint Etienne

Saint-Etienne, , France

Site Status

Hopital Central Strasbourg

Strasbourg, , France

Site Status

Hopital Hautepierre Strasbourg

Strasbourg, , France

Site Status

Chu Toulouse

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Molliex S, Passot S, Futier E, Bonnefoi M, Rancon F, Lemanach Y, Pereira B. Stepped wedge cluster randomised controlled trial to assess the effectiveness of an optimisation strategy for general anaesthesia on postoperative morbidity and mortality in elderly patients (the OPTI-AGED study): a study protocol. BMJ Open. 2018 Jun 19;8(6):e021053. doi: 10.1136/bmjopen-2017-021053.

Reference Type DERIVED
PMID: 29921685 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ANSM

Identifier Type: OTHER

Identifier Source: secondary_id

1508190

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hip Fracture Surgery in Elderly Patients
NCT01199276 COMPLETED PHASE2
Frailty and Postoperative Shock
NCT02669927 COMPLETED